Summary
- Current Price
- As of today, RLAY price is $18.46, down -0.16% in the most recent trading session on
- Current Price All-Time High
- RLAY price is currently -71.32% below its historical high of $64.37 set on
- Market Cap
- RLAY current market cap is $4B, up +543.76% over the past 365 days
- Revenue
- RLAY current annual revenue is $15.36M, up +53.44% year-over-year
- Next Earnings
- The next earnings release for RLAY is on
Profile
| Metric | Value |
|---|---|
| Full Name | Relay Therapeutics, Inc. |
| Ticker | NASDAQ: RLAY |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | relaytx.com |
| Employees | 259 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $18.46 | |
| Price, 1D Change | -0.16% | |
| $4B | ||
| - | ||
| - | ||
| 1.55 | ||
| $15.36M | ||
| Revenue, 1Y Change | +53.44% | |
| -$1.61 | ||
| EPS, 1Y Change | +31.83% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.61 | ||
| EPS Estimate | -$1.63 | N/A |
| EPS Est. Change | -1.10% | N/A |
| $15.36M | ||
| Revenue Estimate | $7.91M | N/A |
| Revenue Est. Change | -48.49% | N/A |
| Current Price | $18.46 | |
| Price Target | $26.00 | - |
| Price Tgt. Change | +40.85% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.47 | -$2.36 | +4.28% | |
| -$1.74 | -$1.61 | +7.53% | |
| -$1.63 | N/A | -1.10% | |
| -$1.64 | N/A | -1.96% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $15.08M | $10.01M | -33.63% | |
| $11.61M | $15.36M | +32.29% | |
| $7.91M | N/A | -48.49% | |
| $16.53M | N/A | +7.68% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $18.46 | |
| $12.78 | ||
| $19.29 | ||
| $13.78 | ||
| $18.66 | ||
| -$0.04 | ||
| 1.55 | ||
| $0.96 | ||
| 41.85 | ||
| 47.65% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $15.36M | ||
| -$1.61 | ||
| $0.00 | ||
| 76.83% | ||
| -$302.74M | ||
| -1,971.59% | ||
| -$276.48M | ||
| -1,800.58% | ||
| -$299.18M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.06 | ||
| 22.61 | ||
| 22.61 | ||
| - | ||
| 3 | ||
| 41.28 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 390.86 | ||
| 4.55 | ||
| -10.27 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $567.06M | ||
| $554.52M | ||
| $621.33M | ||
| $578.28M | ||
| $54.27M | ||
| $25.58M | ||
| $32.46M | ||
| $3.77M | ||
| $7.71M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $291.83M | ||
| $314.54M | ||
| $3.56M | ||
| $56.71M | ||
| $3.56M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$235.46M | ||
| $192.80M | ||
| $1.60M | ||
| $410.00K | ||
| -$235.87M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| JP Morgan | → | |
| Citizens | → | |
| Barclays | → | |
| Goldman Sachs | → | |
| Canaccord Genuity | ||
| JP Morgan | ||
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| Citizens | → |
Analyst sentiment
Institutional ownership
No data
Screeners with RLAY
FAQ
- What is the ticker symbol for Relay Therapeutics, Inc.?
- The ticker symbol for Relay Therapeutics, Inc. is NASDAQ:RLAY
- Does Relay Therapeutics, Inc. pay dividends?
- No, Relay Therapeutics, Inc. does not pay dividends
- What sector is Relay Therapeutics, Inc. in?
- Relay Therapeutics, Inc. is in the Healthcare sector
- What industry is Relay Therapeutics, Inc. in?
- Relay Therapeutics, Inc. is in the Biotechnology industry
- What country is Relay Therapeutics, Inc. based in?
- Relay Therapeutics, Inc. is headquartered in United States
- When did Relay Therapeutics, Inc. go public?
- Relay Therapeutics, Inc. initial public offering (IPO) was on July 16, 2020
- Is Relay Therapeutics, Inc. in the S&P 500?
- No, Relay Therapeutics, Inc. is not included in the S&P 500 index
- Is Relay Therapeutics, Inc. in the NASDAQ 100?
- No, Relay Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Relay Therapeutics, Inc. in the Dow Jones?
- No, Relay Therapeutics, Inc. is not included in the Dow Jones index
- When was Relay Therapeutics, Inc. last earnings report?
- Relay Therapeutics, Inc.'s most recent earnings report was on August 6, 2026
- When does Relay Therapeutics, Inc. report earnings?
- The next expected earnings date for Relay Therapeutics, Inc. is November 5, 2026
Data Sources & References
- RLAY Official Website www.relaytx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1812364/000119312526076739/0001193125-26-076739-index.htm
- RLAY Profile on Yahoo Finance finance.yahoo.com/quote/RLAY
- RLAY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rlay